Business · 25/11/2011Updated: 10/17/2026 · 1 min read
FDA Announces Approval of Adverse Experience Reporting Collection for Licensed Biological Products
Summary
The Food and Drug Administration (FDA) has received approval from the Office of Management and Budget (OMB) to collect information on adverse experiences with licensed biological products and general records, as mandated by the Paperwork Reduction Act of 1995.
Original source language: Federal Register — Health and Human ServicesOpen original release →